JPH0687730A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0687730A JPH0687730A JP26297992A JP26297992A JPH0687730A JP H0687730 A JPH0687730 A JP H0687730A JP 26297992 A JP26297992 A JP 26297992A JP 26297992 A JP26297992 A JP 26297992A JP H0687730 A JPH0687730 A JP H0687730A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- oil
- cosmetic
- glycerin
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 17
- 239000000194 fatty acid Substances 0.000 claims abstract description 17
- 229930195729 fatty acid Natural products 0.000 claims abstract description 17
- 150000001841 cholesterols Chemical class 0.000 claims abstract description 10
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 6
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003974 emollient agent Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 13
- -1 fatty acid ester Chemical class 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 6
- 240000000912 Macadamia tetraphylla Species 0.000 description 6
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000010466 nut oil Substances 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229950004959 sorbitan oleate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、化粧料、さらに詳しく
はエモリエント効果が高く、皮膚の乾燥を防ぎ、使用性
に優れる化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition, and more particularly to a cosmetic composition having a high emollient effect, preventing skin dryness and being excellent in usability.
【0002】[0002]
【従来の技術】皮膚は元来、体内からの水分の蒸発を適
度に抑える機能を有しているが、極度に乾燥した環境に
置かれたり、肌荒れ状態をおこすと、その機能は低下
し、皮膚がざらざらした状態になる。このような場合、
適当な油分を皮膚に与えることにより、しっとりした皮
膚を回復し、水分の異常な蒸散を抑制することが知られ
ている。中でもコレステロール類は高い抱水能を有して
おり、皮膚のなめらかさやしっとりさをより一層向上さ
せることができる。2. Description of the Related Art Originally, the skin has a function of appropriately suppressing the evaporation of water from the body, but if it is placed in an extremely dry environment or if the skin becomes rough, its function deteriorates. The skin becomes rough. In such cases,
It is known that by applying an appropriate oil content to the skin, the moist skin is restored and abnormal evaporation of water is suppressed. Among them, cholesterols have a high water-holding ability and can further improve the smoothness and moistness of the skin.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、コレス
テロール類は単独または非極性油とともに用いると、べ
たつき等の使用面で化粧料としての弊害を生じる。However, when cholesterols are used alone or in combination with a non-polar oil, they cause a problem as a cosmetic in terms of stickiness and the like.
【0004】[0004]
【課題を解決するための手段】本発明者らは、このよう
な事情に鑑み、エモリエント効果が高く、かつ使用面に
優れた化粧料を得るべく鋭意研究を重ねた結果、コレス
テロール誘導体と多価アルコールの脂肪酸エステルを併
用することにより、上記の問題を解決することを見いだ
し、本発明を完成するに至った。すなわち、本発明は、
コレステロール誘導体の1種又は2種以上と、多価アル
コールと脂肪酸のエステル化物の1種又は2種以上とを
含有することを特徴とする化粧料である。In view of such circumstances, the present inventors have conducted earnest studies to obtain a cosmetic having a high emollient effect and an excellent use surface, and as a result, a cholesterol derivative and a polyvalent compound were obtained. The inventors have found that the above problem can be solved by using a fatty acid ester of alcohol together, and have completed the present invention. That is, the present invention is
A cosmetic comprising one or more cholesterol derivatives and one or more esterified products of a polyhydric alcohol and a fatty acid.
【0005】以下、本発明の構成について詳述する。本
発明において用いられるコレステロール誘導体は、コレ
ステロール、コレスタノール、デヒドロコレステロー
ル、ラノリン脂肪酸コレステリル、イソステアリン酸コ
レステリル、12−ヒドロキシステアリン酸コレステリ
ル、リシノール酸コレステリル、マカデミアナッツ油脂
肪酸コレステリル等である。本発明において用いられる
コレステロール誘導体の配合量は、化粧料全量中0.01〜
30重量%が好ましい。0.01重量%未満ではその効果は発
揮されない傾向にあり、30重量%を超えると製品の工程
上好ましくない。The structure of the present invention will be described in detail below. Cholesterol derivatives used in the present invention include cholesterol, cholestanol, dehydrocholesterol, lanolin fatty acid cholesteryl, cholesteryl isostearate, cholesteryl 12-hydroxystearate, cholesteryl ricinoleate, macadamia nut oil fatty acid cholesteryl and the like. The amount of the cholesterol derivative used in the present invention is 0.01 to
30% by weight is preferred. If it is less than 0.01% by weight, the effect tends not to be exhibited, and if it exceeds 30% by weight, it is not preferable in the process of the product.
【0006】本発明において用いられる多価アルコール
と脂肪酸のエステル化物としては、テトラ−2−エチル
ヘキサン酸ペンタエリスリトール、トリ−2−エチルヘ
キサン酸グリセリン等が挙げられる。本発明において用
いられる多価アルコールと脂肪酸のエステル化物の配合
量は、化粧料全量中0.01重量%以上が好ましい。0.01重
量%未満ではコレステロール誘導体のべたつきを抑える
ことができない。Examples of esterified products of polyhydric alcohols and fatty acids used in the present invention include pentaerythritol tetra-2-ethylhexanoate and glycerin tri-2-ethylhexanoate. The amount of the esterified product of the polyhydric alcohol and the fatty acid used in the present invention is preferably 0.01% by weight or more based on the total amount of the cosmetic. If it is less than 0.01% by weight, the stickiness of the cholesterol derivative cannot be suppressed.
【0007】本発明の化粧料には、上記した必須成分の
他に通常化粧料に配合される成分、たとえば、流動パラ
フィン、ワセリン、マイクロクリスタリンワックス、ス
クワラン、アーモンド油、オリーブ油、硬化油、ヒマシ
油、モクロウ、ヤシ油、ミツロウ、ラノリン、カルナバ
ロウ、パーム油等の油分、ラノリン酸、ミリスチン酸、
パルミチン酸、ステアリン酸、イソステアリン酸、オレ
イン酸等の脂肪酸、ラウリルアルコール、セタノール、
ステアリルアルコール、オレイルアルコール等の高級ア
ルコール、ミリスチン酸イソプロピル、ミリスチン酸ミ
リスチル、パルミチン酸イソプロピル等のエステル類、
クエン酸、酒石酸、乳酸等の酸、水酸化ナトリウム、水
酸化カリウム、トリエタノールアミン等のアルカリ、ラ
ウリルジメチルアミノ酢酸ベタイン、モノステアリン酸
グリセリン、ソルビタン脂肪酸エステル、ポリオキシエ
チレン脂肪酸エステル、ポリオキシエチレンアルキルエ
ーテル等の界面活性剤、グリセリン、プロピレングリコ
ール、1,3-ブチレングリコール、ジプロピレングリコー
ル、ソルビトール、ピロリドンカルボン酸ナトリウム、
ポリエチレングリコール、ヒアルロン酸等の保湿剤、酸
化チタン、タルク、カオリン等の粉末、ヒドロキシメト
キシベンゾフェノンまたはそのスルホン酸ナトリウム、
パラジメチルアミノ安息香酸アミル、メトキシケイ皮酸
オクチル、ジパラメトキシケイ皮酸モノ−2−エチルヘ
キサン酸グリセリル等の紫外線吸収剤、パラベン等の防
腐殺菌剤、カルボキシメチルセルロース、アルギン酸ナ
トリウム、カルボキシメチルポリマー等の増粘剤、黄酸
化鉄、チタンエロー、カーサミン等の着色料、グリチル
リチン酸誘導体、グリチルレチン酸誘導体、サリチル酸
誘導体、アラントイン、ユキノシタエキス等の消炎剤、
グルタチオン、アルブチン、アスコルビン酸誘導体等の
美白剤、プラセンタエキス、感光素、パントテニルアル
コール、パントテニルエチルエーテル等の賦活剤、ニン
ジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイ
ニン、メリッサ、セイヨウノコギリソウ、ヘチマ、ユ
リ、オオバク、シャクヤク、センブリ、バーチ、ビワ等
の抽出物、レチノール、ニコチン酸アミド、トコフェロ
ール等のビタミン類などを適宜配合することができる。In the cosmetic of the present invention, in addition to the above-mentioned essential components, components which are usually incorporated in cosmetics, for example, liquid paraffin, petrolatum, microcrystalline wax, squalane, almond oil, olive oil, hydrogenated oil, castor oil. Oil components such as, owl, palm oil, beeswax, lanolin, carnauba wax, palm oil, lanolinic acid, myristic acid,
Fatty acids such as palmitic acid, stearic acid, isostearic acid, oleic acid, lauryl alcohol, cetanol,
Higher alcohols such as stearyl alcohol and oleyl alcohol, esters such as isopropyl myristate, myristyl myristate and isopropyl palmitate,
Acids such as citric acid, tartaric acid, lactic acid, alkalis such as sodium hydroxide, potassium hydroxide, triethanolamine, lauryldimethylaminoacetic acid betaine, glyceryl monostearate, sorbitan fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene alkyl Surfactants such as ether, glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, sorbitol, sodium pyrrolidonecarboxylate,
Moisturizers such as polyethylene glycol and hyaluronic acid, powders such as titanium oxide, talc and kaolin, hydroxymethoxybenzophenone or its sodium sulfonate,
UV absorbers such as amyl paradimethylaminobenzoate, octyl methoxycinnamate, glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, antiseptic agents such as parabens, carboxymethyl cellulose, sodium alginate, carboxymethyl polymer, etc. Thickening agent, yellow iron oxide, titanium yellow, colorants such as cursamine, glycyrrhizic acid derivative, glycyrrhetinic acid derivative, salicylic acid derivative, allantoin, anti-inflammatory agent such as Yukinoshita extract,
Glutathione, arbutin, whitening agents such as ascorbic acid derivative, placenta extract, photosensitizer, activator such as pantothenyl alcohol, pantothenyl ethyl ether, carrot, aloe, mallow, iris, grape, yochinin, melissa, yarrow, loofah, Extracts such as lily, psyllium, peony, assembly, birch, loquat and the like, vitamins such as retinol, nicotinic acid amide, tocopherol and the like can be appropriately added.
【0008】本発明の化粧料の剤型は任意であり、溶液
系、可溶化系、乳化系、粉末分散系、水−油二層系、水
−油−粉末三層系等、どのような剤型でもよい。また、
本発明の化粧料の用途も任意であり、乳液、クリーム、
美容液、パック等のフェーシャル化粧料、ファンデーシ
ョン、口紅、アイシャドー等のメーキャップ化粧料、ボ
ディー用化粧料、芳香化粧料、洗浄料等に用いることが
できる。The cosmetic of the present invention may have any dosage form, such as a solution system, a solubilization system, an emulsion system, a powder dispersion system, a water-oil two-layer system, a water-oil-powder three-layer system, and the like. It may be a dosage form. Also,
The use of the cosmetics of the present invention is also arbitrary, such as emulsions, creams,
It can be used for cosmetics, facial cosmetics such as packs, makeup cosmetics such as foundations, lipsticks and eye shadows, body cosmetics, fragrance cosmetics, and cleaning agents.
【0009】[0009]
【実施例】以下、実施例により本発明をさらに詳細に説
明する。本発明は、これら実施例に限定されるものでは
ない。配合量は、すべて重量%である。なお、これに先
立ち実施例で採用した試験法、評価法を説明する。The present invention will be described in more detail with reference to the following examples. The present invention is not limited to these examples. The blending amounts are all weight%. Prior to this, the test methods and evaluation methods adopted in the examples will be described.
【0010】角層水分量(コンダクタンス値)測定 女性パネル25名の前腕内側部に10日間試料を朝晩適
量を塗布し、皮表角層水分量測定装置(アイ・ビイ・エ
ス(株)MODEL:SKICON-200) に2mmφの中心電極を持つ
プローブを装着し、皮膚表面コンダクタンス値を指標と
して測定した。 Measurement of stratum corneum water content (conductance value) A sample of 25 female panels was applied to the inside of the forearm with an appropriate amount of the sample in the morning and evening, and a skin surface stratum corneum water content measuring device (ABI S Model, Inc. MODEL: SKICON-200) was fitted with a probe having a center electrode of 2 mmφ, and the skin surface conductance value was measured as an index.
【0011】女性パネルによる官能試験 化粧料としての使用性について、女性パネル25名によ
る官能試験を行った。 べたつき感の評価基準 ○ ・・・ 25名中20名以上がべたつかないと評価 △ ・・・ 25名中10名以上20名未満がべたつか
ないと評価 × ・・・ 25名中10名未満がべたつかないと評価 しっとりさの評価基準 ○ ・・・ 25名中20名以上がしっとりすると評価 △ ・・・ 25名中10名以上20名未満がしっとり
すると評価 × ・・・ 25名中10名未満がしっとりすると評価 Sensory test by female panel A sensory test was conducted by 25 female panels on the usability as cosmetics. Criteria for evaluation of stickiness ○: 20 or more out of 25 people evaluated as non-greasy △: 10 or more out of 25 and less than 20 people evaluated as non-sticky ×: less than 10 out of 25 people sticky Evaluation of No Moisture Evaluation criteria of moistness ○ ・ ・ ・ Evaluation when 20 or more people out of 25 people moist △ △ Evaluation of 10 to 20 people out of 25 people when moist × × ・ ・ ・ less than 10 people out of 25 people Evaluated to be moist
【0012】実施例1、比較例1、2 表1に示すクリームを製造し、上記基準に基づき評価し
た。なお、製法は、Aの油相部をBの水相部に加えて、
乳化機で乳化してクリームを得た。結果も併せて表1に
示す。Example 1, Comparative Examples 1 and 2 Creams shown in Table 1 were produced and evaluated according to the above criteria. In addition, the manufacturing method is to add the oil phase part of A to the water phase part of B,
It was emulsified with an emulsifying machine to obtain a cream. The results are also shown in Table 1.
【0013】[0013]
【表1】 [Table 1]
【0014】表1より、本発明の実施例1は皮膚に潤い
を与え、しかも使用性に優れるものであることがわか
る。From Table 1, it can be seen that Example 1 of the present invention moisturizes the skin and is excellent in usability.
【0015】 実施例2 化粧水 (重量%) A.アルコール相 エタノール 5.0 ポリオキシエチレンノニルフェニルエーテル 2.0 マカデミアナッツ油脂肪酸コレステリル 0.02 トリ−2−エチルヘキサン酸グリセリン 0.03 パラオキシ安息香酸メチル 0.1 香料 適量 B.水相 1,3−ブチレングリコール 5.0 グリセリン 5.0 アラントイン 0.3 セリン 0.5 乳酸 0.2 メタリン酸ナトリウム 0.05 着色料 適量 精製水 残余 製法 Aのアルコール相をBの水相に添加し、可溶化して化粧
水を得た。Example 2 Lotion (wt%) A. Alcohol phase Ethanol 5.0 Polyoxyethylene nonylphenyl ether 2.0 Macadamia nut oil fatty acid cholesteryl 0.02 Glycerin tri-2-ethylhexanoate 0.03 Methyl paraoxybenzoate 0.1 Fragrance B. Aqueous phase 1,3-butylene glycol 5.0 Glycerin 5.0 Allantoin 0.3 Serine 0.5 Lactic acid 0.2 Sodium metaphosphate 0.05 Coloring agent Appropriate amount of purified water Residual production method Alcohol phase of A to B aqueous phase It was added and solubilized to obtain a lotion.
【0016】 実施例3 美容液 (重量%) A.油相 コレステロール 0.5 テトラ−2−エチルヘキサン酸ペンタエリスリトール 0.2 B.水相 エタノール 5.0 グリチルリチン酸 0.1 ポリエチレングリコール 600 3.0 カルボキシビニルポリマー 0.2 グリセリン 10.0 アロエエキス 0.1 アルブチン 1.0 水酸化カリウム 0.1 パラオキシ安息香酸メチル 0.1 メタリン酸ナトリウム 0.05 精製水 残余 製法 Aの油相をBの水相に添加後、乳化機で乳化し美容液を
得た。Example 3 Beauty Serum (wt%) A. Oil phase Cholesterol 0.5 Tetra-2-ethylhexanoic acid pentaerythritol 0.2 B. Water phase Ethanol 5.0 Glycyrrhizinate 0.1 Polyethylene glycol 600 3.0 Carboxyvinyl polymer 0.2 Glycerin 10.0 Aloe extract 0.1 Arbutin 1.0 Potassium hydroxide 0.1 Methyl paraoxybenzoate 0.1 Metaline Sodium acid 0.05 Purified water Residual method The oil phase of the method A was added to the water phase of B, and then emulsified with an emulsifier to obtain a beauty essence.
【0017】 実施例4 乳液 (重量%) A.油相 セタノール 0.8 セトステアリルアルコール 1.4 ラノリン脂肪酸コレステリル 2.0 テトラ−2−エチルヘキサン酸ペンタエリスリトール 4.0 流動パラフィン 3.0 メトキシケイ皮酸オクチル 0.5 モノステアリン酸ソルビタン 0.5 自己乳化型モノステアリン酸グリセリル 1.0 ポリオキシプロピレンステアリルエーテル 0.5 ステアリン酸 0.5 パラオキシ安息香酸エチル 0.2 B.水相 グリセリン 3.0 ヒアルロン酸ナトリウム 0.1 カルボキシビニルポリマー 0.15 水酸化カリウム 0.15 エデト酸三ナトリウム 0.1 ニコチン酸アミド 0.1 牛脾臓エキス 0.1 香料 適量 精製水 残余 製法 Aの油相部とBの水相部をそれぞれ70℃に加熱溶解さ
せ、Aの油相部をBの水相部に加え、乳化機で乳化す
る。乳化物を熱交換機を用いて冷却し、乳液を得た。Example 4 Emulsion (wt%) A. Oil phase cetanol 0.8 cetostearyl alcohol 1.4 lanolin fatty acid cholesteryl 2.0 tetra-2-ethylhexanoate pentaerythritol 4.0 liquid paraffin 3.0 octyl methoxycinnamate 0.5 sorbitan monostearate 0.5 Self-emulsifying glyceryl monostearate 1.0 Polyoxypropylene stearyl ether 0.5 Stearic acid 0.5 Ethyl paraoxybenzoate 0.2 B. Aqueous phase Glycerin 3.0 Sodium hyaluronate 0.1 Carboxyvinyl polymer 0.15 Potassium hydroxide 0.15 Trisodium edetate 0.1 Nicotinic acid amide 0.1 Bovine spleen extract 0.1 Perfume proper amount Purified water Residual production method A The oil phase part of B and the water phase part of B are respectively dissolved by heating at 70 ° C., the oil phase part of A is added to the water phase part of B, and the mixture is emulsified by an emulsifying machine. The emulsion was cooled using a heat exchanger to obtain an emulsion.
【0018】 実施例5 クリーム (重量%) A.油相 スクワラン 8.0 ステアリン酸 3.0 ステアリルアルコール 3.0 自己乳化型モノステアリン酸グリセリル 6.0 ミツロウ 3.0 12−ヒドロキシステアリン酸グリセリル 3.0 トリ−2−エチルヘキサン酸グリセリン 2.0 dl−α−トコフェロール 0.1 ヒドロキシメトキシベンゾフェノン 1.0 パラオキシ安息香酸ブチル 0.2 B.水相 プロピレングリコール 5.0 グリセリン 5.0 トリエタノールアミン 1.0 dl−ピロリドンカルボン酸ナトリウム液 1.0 卵殻膜ケラチン液 0.1 精製水 残余 製法 実施例4と同じ。Example 5 Cream (wt%) A. Oil phase Squalane 8.0 Stearic acid 3.0 Stearyl alcohol 3.0 Self-emulsifying glyceryl monostearate 6.0 Beeswax 3.0 12-Hydroxystearate glyceryl 3.0 Tri-2-ethylhexanoate glycerin 2.0 dl-α-tocopherol 0.1 hydroxymethoxybenzophenone 1.0 butyl paraoxybenzoate 0.2 B.I. Aqueous phase Propylene glycol 5.0 Glycerin 5.0 Triethanolamine 1.0 Sodium dl-pyrrolidonecarboxylate 1.0 Egg shell membrane keratin solution 0.1 Purified water Residual production method Same as in Example 4.
【0019】 実施例6 サンケア (重量%) A.油相 メトキシケイ皮酸オクチル 5.0 テトラヒドロキシベンゾフェノン 2.0 ステアリン酸 4.0 セタノール 1.0 ステアリン酸イソセチル 1.0 ピバリン酸イソデシル 5.0 マカデミアナッツ油脂肪酸コレステリル 4.0 トリ−2−エチルヘキサン酸グリセリン 6.0 パラオキシ安息香酸ブチル 0.2 香料 適量 B.水相 グリセリン 5.0 カルボキシルビニルポリマー 0.1 トリエタノールアミン 0.1 精製水 残余 製法 実施例4と同じ。Example 6 Sun Care (wt%) A. Oil phase Octyl methoxycinnamate 5.0 Tetrahydroxybenzophenone 2.0 Stearic acid 4.0 Cetanol 1.0 Isocetyl stearate 1.0 Isodecyl pivalate 5.0 Macadamia nut oil fatty acid cholesteryl 4.0 Tri-2-ethylhexane Acid glycerin 6.0 Butyl paraoxybenzoate 0.2 Perfume Suitable amount B. Aqueous phase Glycerin 5.0 Carboxyl vinyl polymer 0.1 Triethanolamine 0.1 Purified water Residual production method Same as in Example 4.
【0020】 実施例7 ファンデーション (重量%) A.油相 流動パラフィン 5.0 ミリスチン酸ミリスチル 2.0 ポリイソブテン 2.0 オレイルアルコール 2.0 ステアリルアルコール 2.0 オレイン酸ポリオキシエチレンソルビタン 0.5 パラオキシ安息香酸ブチル 0.1 テトラ−2−エチルヘキサン酸ペンタエリスリトール 1.0 マカデミアナッツ油脂肪酸コレステリル 0.1 香料 適量 B.粉末 タルク 5.0 酸化チタン 5.0 酸化鉄 4.0 C.水相 ケイ酸アルミニウムマグネシウム 0.75 キサンタンガム 0.15 グリセリン 4.0 クエン酸 0.3 精製水 残余 製法 Aの油相部とCの水相部をそれぞれ70℃に加熱溶解
し、Aの油相部にBの水相部を加え、乳化機で乳化す
る。これを50℃まで冷却後、Bの粉末を加えよく攪拌
し、ファンデーションを得た。Example 7 Foundation (wt%) A. Oil phase Liquid paraffin 5.0 Myristyl myristate 2.0 Polyisobutene 2.0 Oleyl alcohol 2.0 Stearyl alcohol 2.0 Polyoxyethylene sorbitan oleate 0.5 Butyl paraoxybenzoate 0.1 Tetra-2-ethylhexanoic acid Pentaerythritol 1.0 Macadamia nut oil fatty acid cholesteryl 0.1 Fragrance Suitable amount B. Powder talc 5.0 Titanium oxide 5.0 Iron oxide 4.0 C.I. Water phase Aluminum magnesium silicate 0.75 Xanthan gum 0.15 Glycerin 4.0 Citric acid 0.3 Purified water Residual production method The oil phase part of A and the water phase part of C are dissolved by heating at 70 ° C. respectively, and the oil phase of A The water phase part of B is added to the part and emulsified with an emulsifying machine. After cooling to 50 ° C., the powder of B was added and well stirred to obtain a foundation.
【0021】 実施例8 クレンジングローション (重量%) A.油相 ポリオキシエチレンオレイルエーテル 0.3 流動パラフィン 10.0 ミツロウ 2.0 パルミチン酸セチル 2.0 モノステアリン酸ソルビタン 2.0 トリ−2−エチルヘキサン酸グリセリン 4.0 マカデミアナッツ油脂肪酸コレステリル 0.1 香料 適量 B.水相 オレイン酸ポリオキシエチレンソルビタン 4.0 パラオキシ安息香酸ブチル 0.2 精製水 残余 製法 Aの油相部とBの水相部をそれぞれ70℃に加熱溶解
し、Bの水相部にAの油相部を加え、乳化機で乳化す
る。乳化物を熱交換を用いて冷却し、クレンジングロー
ションを得た。Example 8 Cleansing Lotion (wt%) A. Oil phase Polyoxyethylene oleyl ether 0.3 Liquid paraffin 10.0 Beeswax 2.0 Cetyl palmitate 2.0 Sorbitan monostearate 2.0 Glycerin tri-2-ethylhexanoate 4.0 Macadamia nut oil Fatty acid cholesteryl 0.1 Perfume proper amount B. Aqueous phase Polyoxyethylene sorbitan oleate 4.0 Butyl paraoxybenzoate 0.2 Purified water Residual production method The oil phase part of A and the water phase part of B are dissolved by heating to 70 ° C. Add the oil phase and emulsify with an emulsifier. The emulsion was cooled using heat exchange to give a cleansing lotion.
【0022】 実施例9 口紅 (重量%) A.油相部 流動パラフィン 残 部 グリセリルイソステアレート 1.0 ヒマシ油 40.0 カルナバロウ 2.0 固形パラフィン 7.0 キャンデリラロウ 0.5 マカデミアナッツ油脂肪酸コレステリル 0.1 トリ−2−エチルヘキサン酸グリセリン 4.0 香料 適量 δ−トコフェロール 0.03 B.粉末部 赤色202号 0.5 赤色204号 2.3 橙色201号 0.2 二酸化チタン 2.0 製法 Aの油相部を80℃で溶解し、Bの粉末部を加え、均一
に分散する。混合物をロールミルで練り、容器に流し込
み冷却して固め、口紅を得た。Example 9 Lipstick (wt%) A. Oil phase Liquid paraffin Remainder Glyceryl isostearate 1.0 Castor oil 40.0 Carnauba wax 2.0 Solid paraffin 7.0 Candelilla wax 0.5 Macadamia nut oil fatty acid cholesteryl 0.1 Tri-2-ethylhexanoate glycerin 4 0.0 Fragrance Appropriate amount δ-tocopherol 0.03 B.I. Powder part Red No. 202 0.5 Red No. 204 2.3 Orange 201 No. 0.2 Titanium dioxide 2.0 Manufacturing method The oil phase part of A is melt | dissolved at 80 degreeC, the powder part of B is added, and it disperses uniformly. The mixture was kneaded with a roll mill, poured into a container, cooled and solidified to obtain a lipstick.
【0023】[0023]
【発明の効果】コレステロール誘導体および多価アルコ
ールのエステル化物を含有させることにより、べたつき
がなくエモリエント効果の高い化粧料が得られる。By containing a cholesterol derivative and an esterified product of a polyhydric alcohol, a cosmetic having a high emollient effect without stickiness can be obtained.
Claims (1)
と、多価アルコールと脂肪酸のエステル化物の1種又は
2種以上とを含有することを特徴とする化粧料。1. A cosmetic comprising one or more cholesterol derivatives and one or more esterified products of a polyhydric alcohol and a fatty acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26297992A JPH0687730A (en) | 1992-09-04 | 1992-09-04 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26297992A JPH0687730A (en) | 1992-09-04 | 1992-09-04 | Cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0687730A true JPH0687730A (en) | 1994-03-29 |
Family
ID=17383210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP26297992A Pending JPH0687730A (en) | 1992-09-04 | 1992-09-04 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0687730A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08109122A (en) * | 1994-10-07 | 1996-04-30 | Kanebo Ltd | Skin cosmetic |
| JPH09315931A (en) * | 1996-05-28 | 1997-12-09 | Kanebo Ltd | Cosmetic material for skin |
| US6224888B1 (en) | 1999-02-12 | 2001-05-01 | The Procter & Gamble Company | Cosmetic compositions |
| US6309657B2 (en) | 1999-02-12 | 2001-10-30 | The Procter & Gamble Company | Cosmetic compositions |
| US6455055B1 (en) | 1999-02-12 | 2002-09-24 | The Procter & Gamble Company | Cosmetic compositions |
| JP2003012454A (en) * | 2001-06-26 | 2003-01-15 | Kanebo Ltd | Method of sales of cosmetic and cosmetic used therefor |
| WO2005046625A1 (en) * | 2003-11-14 | 2005-05-26 | Shiseido Company, Ltd. | Cosmetic composition |
| US8980808B2 (en) | 2011-08-03 | 2015-03-17 | Cognis Ip Management Gmbh | Lubricant compositions with improved oxidation stability and service life |
-
1992
- 1992-09-04 JP JP26297992A patent/JPH0687730A/en active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08109122A (en) * | 1994-10-07 | 1996-04-30 | Kanebo Ltd | Skin cosmetic |
| JPH09315931A (en) * | 1996-05-28 | 1997-12-09 | Kanebo Ltd | Cosmetic material for skin |
| US6224888B1 (en) | 1999-02-12 | 2001-05-01 | The Procter & Gamble Company | Cosmetic compositions |
| US6309657B2 (en) | 1999-02-12 | 2001-10-30 | The Procter & Gamble Company | Cosmetic compositions |
| US6455055B1 (en) | 1999-02-12 | 2002-09-24 | The Procter & Gamble Company | Cosmetic compositions |
| US6528071B2 (en) | 1999-02-12 | 2003-03-04 | The Procter & Gamble Company | Cosmetic compositions |
| JP2003012454A (en) * | 2001-06-26 | 2003-01-15 | Kanebo Ltd | Method of sales of cosmetic and cosmetic used therefor |
| WO2005046625A1 (en) * | 2003-11-14 | 2005-05-26 | Shiseido Company, Ltd. | Cosmetic composition |
| US8481061B2 (en) | 2003-11-14 | 2013-07-09 | Shiseido Company, Ltd. | Cosmetic composition |
| US8980808B2 (en) | 2011-08-03 | 2015-03-17 | Cognis Ip Management Gmbh | Lubricant compositions with improved oxidation stability and service life |
| US9371500B2 (en) | 2011-08-03 | 2016-06-21 | Cognis Ip Management Gmbh | Lubricant compositions with improved oxidation stability and service life |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0780116B1 (en) | External skin preparation | |
| JPWO1997002803A1 (en) | topical skin preparations | |
| JP2002080338A (en) | Antiaging skin care preparation | |
| JP2002003373A (en) | Skin care preparation | |
| JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
| JP4518367B2 (en) | Pore reducing agent | |
| JP2002003358A (en) | Skin care preparation | |
| CA1142854A (en) | Method and compositions for the treatment of seborrhea | |
| JPH0687730A (en) | Cosmetic | |
| JPH04270212A (en) | Skin external agent | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JP2001278783A (en) | Collagen production promoter | |
| JPH07138125A (en) | Topical skin | |
| JPS6351312A (en) | Skin beautifying cosmetic | |
| JPH06157240A (en) | Skin external agent | |
| JP2000344697A (en) | Long-chain branched alcohol, cosmetic and external preparation using the same | |
| JPH07215839A (en) | Skin external agent | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
| JP3093353B2 (en) | External preparation for skin | |
| JP3912722B2 (en) | Topical skin preparation | |
| FR2777779A1 (en) | Skin care cosmetic composition for treating photo aged, dry, lined or wrinkled skin | |
| JP3349544B2 (en) | Skin cosmetics | |
| JP2720247B2 (en) | External preparation for skin | |
| JPH08104610A (en) | Face-washing cosmetic | |
| JP2001039816A (en) | Inhibitor against formation of crosslink in collagen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20020903 |